Search research articles
Contact Us
Filters
Showing results (101-110 of 246) with videos related to
Page
of 25
Sort By:
British Journal of Clinical Pharmacology
|
June 5, 2023
Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial
Line Uhrenholt, Kirsten Duch, Robin Christensen, et al.
Journal of Autoimmunity
|
November 2, 2005
Anti-TNF therapy: where have we got to in 2005?
Marc Feldmann, Fionula M Brennan, Brian M J Foxwell, et al.
Seminars in Arthritis and Rheumatism
|
January 7, 2021
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis
Lee S Simon, Peter C Taylor, Ernest H Choy, et al.
BMJ Open
|
February 17, 2022
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients' satisfaction: a cross-sectional survey by patient organisations
Kayoko Kaneko, Daniel Prieto-Alhambra, Clare Jacklin, et al.
Clinical and Experimental Rheumatology
|
October 19, 2021
The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells
Sam Weston, Joanne L Macdonald, Lynn M Williams, et al.
RMD Open
|
February 22, 2023
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
Maxime Dougados, Peter C Taylor, Clifton O Bingham, et al.
Rheumatology and Therapy
|
April 14, 2026
Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting
Peter C Taylor, Aditi Kadakia, Jack Milligan, et al.
Pathology
|
April 15, 2020
A simple and expedient PCR format for rapid molecular screening of methicillin-resistant Staphylococcus aureus in Amies gel swabs
Christopher J McIver, Ranapanada Nilushika D De Silva, Noel Er, et al.
RMD Open
|
December 11, 2021
Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis-going beyond treat to target
Peter C Taylor, Mart Van de Laar, Andrew Laster, et al.
Plos One
|
September 12, 2015
Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study
Anton Wulf Christensen, Simon Tarp, Daniel E Furst, et al.
Page
of 25
Search research articles
Search
Showing results (101-110 of 246) with videos related to
Sort By:
Page
of 25
British Journal of Clinical Pharmacology
|
June 5, 2023
Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial
Line Uhrenholt, Kirsten Duch, Robin Christensen, et al.
Journal of Autoimmunity
|
November 2, 2005
Anti-TNF therapy: where have we got to in 2005?
Marc Feldmann, Fionula M Brennan, Brian M J Foxwell, et al.
Seminars in Arthritis and Rheumatism
|
January 7, 2021
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis
Lee S Simon, Peter C Taylor, Ernest H Choy, et al.
BMJ Open
|
February 17, 2022
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients' satisfaction: a cross-sectional survey by patient organisations
Kayoko Kaneko, Daniel Prieto-Alhambra, Clare Jacklin, et al.
Clinical and Experimental Rheumatology
|
October 19, 2021
The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells
Sam Weston, Joanne L Macdonald, Lynn M Williams, et al.
RMD Open
|
February 22, 2023
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
Maxime Dougados, Peter C Taylor, Clifton O Bingham, et al.
Rheumatology and Therapy
|
April 14, 2026
Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting
Peter C Taylor, Aditi Kadakia, Jack Milligan, et al.
Pathology
|
April 15, 2020
A simple and expedient PCR format for rapid molecular screening of methicillin-resistant Staphylococcus aureus in Amies gel swabs
Christopher J McIver, Ranapanada Nilushika D De Silva, Noel Er, et al.
RMD Open
|
December 11, 2021
Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis-going beyond treat to target
Peter C Taylor, Mart Van de Laar, Andrew Laster, et al.
Plos One
|
September 12, 2015
Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study
Anton Wulf Christensen, Simon Tarp, Daniel E Furst, et al.
Page
of 25